Pharma Invest ApS: Financial statements 2025
CVR: 44073110
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Invest ApS (CVR 44073110) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -24,376 and a net result of DKK -1,028,115 compared with DKK 179,023 the year before. Equity in the 2025 report amounted to DKK -489,818. The company had 1 employee in the financial year.
- Gross Profit
- DKK -24,376
- Profit/Loss
- DKK -1,028,115
- Equity
- DKK -489,818
- Total Assets
- DKK 1,159,140
- Employees
- 1
Official annual report
How creditworthy is Pharma Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Invest ApS has published its annual report for 2024. Gross profit came to DKK -18,500, and the net result was DKK 179,023.
About Pharma Invest ApS
Pharma Invest ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Investering for egen regning. The management consists of Mads Ulrich. The company is owned by FFC A/S. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -24,376 and a net result of DKK -1,028,115 compared with DKK 179,023 the year before. Equity in the 2025 report amounted to DKK -489,818.